Related Experiment Videos
Recombinant immune interferon inhibits leukemic cell growth by a monocyte-macrophage-mediated mechanism
Abstract:
We have investigated direct and monocyte-macrophage (Mono/M phi)-mediated indirect effects of recombinant immune interferon (IFN-gamma) on the growth of established leukemic cell lines (K562, KG1, ML1, HL60, U937, and THP1). The direct antiproliferative effects of IFN-gamma on these leukemic cells were mild or negligible, when estimated by 3H-thymidine incorporation. Indirect effects were assessed by the growth pattern of leukemic cells cocultured with Mono/M phi that were pretreated with INF-gamma. While the leukemic cell growth was slightly suppressed by untreated Mono/M phi, this suppression was significantly augmented by the treatment of Mono/M phi with IFN-gamma (10-10,000 U/ml). In addition, the indirect effects of IFN-gamma on leukemic cell growth were examined at different stages of maturation of Mono/M phi. The augmentation of cytotoxicity was detected only when mature Mono/M phi were treated with INF-gamma. This suggests that IFN-gamma acts on tissue macrophages and augments their cytotoxicity against leukemic cells.
Insights
Recombinant immune interferon-gamma (IFN-gamma) showed minimal direct impact on leukemia cell growth. However, IFN-gamma significantly enhanced the anti-leukemic effects of mature monocytes and macrophages (Mono/M phi).
Area of Science:
- Immunology
- Cell Biology
- Hematology
Background:
- Interferon-gamma (IFN-gamma) is a cytokine with known immunomodulatory functions.
- Monocytes and macrophages (Mono/M phi) play crucial roles in immune responses and cancer surveillance.
- Understanding the interplay between IFN-gamma and immune cells in leukemia is vital for therapeutic development.
Purpose of the Study:
- To investigate the direct and indirect effects of recombinant IFN-gamma on the proliferation of various established human leukemia cell lines.
- To determine if IFN-gamma modulates the anti-leukemic activity of monocytes and macrophages.
Main Methods:
- Leukemia cell lines (K562, KG1, ML1, HL60, U937, THP1) were exposed to IFN-gamma.
- Leukemic cells were co-cultured with monocytes/macrophages pre-treated with varying concentrations of IFN-gamma.
- Cell proliferation was assessed using 3H-thymidine incorporation.
- The maturation stage of monocytes/macrophages was considered in co-culture experiments.
Main Results:
- Direct antiproliferative effects of IFN-gamma on leukemia cell lines were found to be mild or negligible.
- Pre-treatment of monocytes/macrophages with IFN-gamma significantly augmented their ability to suppress leukemic cell growth.
- This enhanced cytotoxic effect was observed specifically when mature monocytes/macrophages were treated with IFN-gamma.
Conclusions:
- IFN-gamma primarily exerts its anti-leukemic effects indirectly through monocytes and macrophages.
- Mature monocytes and macrophages are key effector cells whose anti-leukemic cytotoxicity is potentiated by IFN-gamma.
- These findings suggest a therapeutic strategy involving IFN-gamma to enhance macrophage-mediated clearance of leukemia cells.